Biogen shares dropped over 7% in premarket trading. The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...
网页链接Biogen shares dropped over 7% in premarket trading. The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...
网页链接
精彩评论